Furthermore, following PDH knockdown (Figure 4F,G), the abundance of α-KG did not increase even after CaLac treatment, which confirmed the necessity for PDH activation in cancer cells for an increase of α-KG (Figure 4H). The gene discussed is PDP1; the disease is cancer.